Nothing Special   »   [go: up one dir, main page]

ATE417125T1 - Diagnose von einer klinischen infektion einer wunde - Google Patents

Diagnose von einer klinischen infektion einer wunde

Info

Publication number
ATE417125T1
ATE417125T1 AT02774985T AT02774985T ATE417125T1 AT E417125 T1 ATE417125 T1 AT E417125T1 AT 02774985 T AT02774985 T AT 02774985T AT 02774985 T AT02774985 T AT 02774985T AT E417125 T1 ATE417125 T1 AT E417125T1
Authority
AT
Austria
Prior art keywords
wound
clinical infection
protease
marker
diagnosis
Prior art date
Application number
AT02774985T
Other languages
English (en)
Inventor
Breda Cullen
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Application granted granted Critical
Publication of ATE417125T1 publication Critical patent/ATE417125T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Winding, Rewinding, Material Storage Devices (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT02774985T 2001-11-05 2002-11-05 Diagnose von einer klinischen infektion einer wunde ATE417125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0126534A GB2381452B (en) 2001-11-05 2001-11-05 Wound monitoring

Publications (1)

Publication Number Publication Date
ATE417125T1 true ATE417125T1 (de) 2008-12-15

Family

ID=9925173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774985T ATE417125T1 (de) 2001-11-05 2002-11-05 Diagnose von einer klinischen infektion einer wunde

Country Status (8)

Country Link
US (1) US7794925B2 (de)
EP (1) EP1453970B1 (de)
AT (1) ATE417125T1 (de)
AU (1) AU2002341191A1 (de)
DE (1) DE60230320D1 (de)
ES (1) ES2316621T3 (de)
GB (1) GB2381452B (de)
WO (1) WO2003040406A2 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2448790C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Electric lancet actuator
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
WO2002100252A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Blood sampling apparatus and method
EP1404235A4 (de) 2001-06-12 2008-08-20 Pelikan Technologies Inc Verfahren und gerät für eine auf einer blutentnahmekartusche integrierte lanzettenvorrichtung
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
JP4209767B2 (ja) 2001-06-12 2009-01-14 ペリカン テクノロジーズ インコーポレイテッド 皮膚の性状の一時的変化に対する適応手段を備えた自動最適化形切開器具
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (de) 2003-09-29 2009-09-16 Pelikan Technologies Inc Verfahren und apparatur für eine verbesserte probeneinfangvorrichtung
EP1680014A4 (de) 2003-10-14 2009-01-21 Pelikan Technologies Inc Verfahren und gerät für eine variable anwenderschnittstelle
EP1692510B1 (de) * 2003-11-03 2008-01-02 Ethicon, Inc. Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (de) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme
EP1751546A2 (de) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Bedruckbares wassergel für biosensoren
EP1765194A4 (de) 2004-06-03 2010-09-29 Pelikan Technologies Inc Verfahren und gerät für eine flüssigkeitsentnahmenvorrichtung
GB0413001D0 (en) * 2004-06-10 2004-07-14 Johnson & Johnson Medical Ltd Diagnostic and prognostic
DE602005021782D1 (de) * 2004-06-11 2010-07-22 Systagenix Wound Man Ip Co Bv Wundinfektionsdiagnose und -prognose durch messung einer phospholipase a2 in wundflüssigkeit
GB2415039B (en) 2004-06-11 2008-11-12 Johnson & Johnson Medical Ltd Diagnosis and prognosis
GB2418145A (en) * 2004-09-17 2006-03-22 Ethicon Inc Wound treatment system
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
GB0520405D0 (en) * 2005-10-07 2005-11-16 Imp College Innovations Ltd Biological agents and method
JP2010512516A (ja) * 2006-12-07 2010-04-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 分析物の効率的かつ正確な検出のための材料および方法
GB2447865A (en) 2007-03-30 2008-10-01 Ethicon Inc Diagnostic markers of wound infection
GB0806186D0 (en) * 2008-04-04 2008-05-14 Axis Shield Diagnostics Ltd Method
GB2459098A (en) * 2008-04-08 2009-10-14 Ethicon Inc Genetic markers of wound development
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
PL2291640T3 (pl) 2008-05-20 2019-07-31 University Health Network Urządzenie i sposób obrazowania i monitorowania w oparciu o fluorescencję
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
WO2010133589A1 (en) 2009-05-18 2010-11-25 Technische Universität Graz Method for detecting a wound infection
WO2010151878A2 (en) 2009-06-26 2010-12-29 University Of Florida Research Foundation, Inc. Rapid bed-side measurement of neutrophil elastase activity in biological fluids
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
EP2671081A2 (de) * 2011-01-31 2013-12-11 Systagenix Wound Management IP Co. BV. Wundprognose
GB201116523D0 (en) * 2011-09-23 2011-11-09 Systagenix Wound Man Ip Co Bv Wound prognosis
US10226212B2 (en) 2012-04-12 2019-03-12 Elwha Llc Appurtenances to cavity wound dressings
US9084530B2 (en) 2012-04-12 2015-07-21 Elwha Llc Computational methods and systems for reporting information regarding appurtenances to wound dressings
US10158928B2 (en) 2012-04-12 2018-12-18 Elwha Llc Appurtenances for reporting information regarding wound dressings
US10130518B2 (en) 2012-04-12 2018-11-20 Elwha Llc Appurtenances including sensors for reporting information regarding wound dressings
US9024751B2 (en) 2012-04-12 2015-05-05 Elwha Llc Dormant to active appurtenances for reporting information regarding wound dressings
US10265219B2 (en) 2012-04-12 2019-04-23 Elwha Llc Wound dressing monitoring systems including appurtenances for wound dressings
PL3171765T3 (pl) 2014-07-24 2022-01-03 University Health Network Zbieranie i analiza danych do celów diagnostycznych
PL3436012T3 (pl) 2016-03-30 2024-04-08 Convatec Technologies Inc. Zmodyfikowany opatrunek do ran
UY37178A (es) * 2016-03-30 2017-10-31 Convatec Technologies Inc Detección de infección microbiana en heridas
US11453905B2 (en) 2016-04-18 2022-09-27 Trubac, LTD. Method of detecting bacterial infection in a biological sample
EP3901277A1 (de) 2020-04-24 2021-10-27 Paul Hartmann AG Verfahren und vorrichtung zur beurteilung des zustandes einer wunde eines patienten
EP3901276A1 (de) 2020-04-24 2021-10-27 Paul Hartmann AG Verfahren und vorrichtung zur beurteilung des zustandes einer wunde eines patienten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2323166B (en) 1997-03-12 2001-04-11 Johnson & Johnson Medical Method and apparatus for mapping the condition of a wound
AU743099B2 (en) 1997-06-09 2002-01-17 Systagenix Wound Management Ip Co. B.V. Novel impaired wound model
RU2146367C1 (ru) * 1997-07-22 2000-03-10 Гуменюк Сергей Евгеньевич Способ прогнозирования течения раневого процесса
US5912114A (en) * 1997-09-12 1999-06-15 Johnson & Johnson Medical, Inc. Wound diagnosis by quantitating cortisol in wound fluids
GB2340235A (en) * 1998-08-05 2000-02-16 Johnson & Johnson Medical Ltd Monitoring bacterial contamination of a wound involving assay of adenosine triphosphate
CA2403371A1 (en) * 2000-02-10 2001-08-16 Timothy F. Murphy A method for detecting bacterial exacerbations of chronic lung disease

Also Published As

Publication number Publication date
GB0126534D0 (en) 2002-01-02
WO2003040406A3 (en) 2003-10-16
ES2316621T3 (es) 2009-04-16
US20050079542A1 (en) 2005-04-14
GB2381452A (en) 2003-05-07
AU2002341191A1 (en) 2003-05-19
US7794925B2 (en) 2010-09-14
EP1453970A2 (de) 2004-09-08
EP1453970B1 (de) 2008-12-10
DE60230320D1 (de) 2009-01-22
GB2381452B (en) 2005-08-10
WO2003040406A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
DE60323466D1 (de) Gerät und methode zur analytischen messung und immuntest
JP2014503252A (ja) 感知パッチ用途
DE50304023D1 (de) Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE60315151D1 (de) Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
WO2006030232A3 (en) Monitoring of wounds by measurement of protease and protease inhibitor levels in wound fluids
DE60110407D1 (de) Reagenz zur bestimmung von blutplättchen-mikroteilchen
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE431556T1 (de) Bestimmung von kurzkettiger srl- alkoholdehydrogenase (dhrs4) als biomarker für entzündungen und infektionen
ATE356667T1 (de) Analysegerät für biologische flüssigkeiten
DE50103030D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE60234821D1 (de) Messverfahren für vollblut
EA200301271A1 (ru) Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DE60231144D1 (de) Test für niedrigmolekulares heparin, system und reagenz dafür
ATE355389T1 (de) Verfahren zur diagnose von schizophrenie
BR0317404A (pt) Variantes do fator xiia
ATE313801T1 (de) Chp als marker für sepsis
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EP1294214A3 (de) Verfahren zur Leuchtmittelüberwachung von Lichtrufsystemen und Lichtrufsystem
DE502005003903D1 (de) Diagnose von sepsis durch selektive bestimmung der sod) in patientenproben
DE60034660D1 (de) Monoklonaler antikörper gegen protein c inhibitor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties